Cardiovascular diseases
Conditions
Interventions
ABG:Supplementation of ABG+10 supplied by Pharmactive
Placebo:Supplementation of placebo supplied by Pharmactive
Sponsors
Center for Research and Instrumentation (CRIM) UKM
Eligibility
Sex/Gender
All
Age
35 Years to 65 Years
Inclusion criteria
Inclusion criteria: Malaysian citizen Age 35 to 65 Able to read and write in Malay or English language Controlled hypertension on stable medication regimen for = 8 weeks prior to randomization [systolic BP (SBP) = 140 mmHg and/or diastolic BP (DBP) = 90 mmHg]
Exclusion criteria
Exclusion criteria: Uncontrolled hypertension [systolic BP (SBP) > 140 mmHg and/or diastolic BP (DBP) > 90 mmHg] Diagnosed hyperlipidemia (total cholesterol = 5.2 mmol/L or on lipid-lowering medication) Diagnosed diabetes (HbA1c = 6.3%, or on antidiabetic medication) Unstable medical conditions (e.g. Inflammatory bowel disease, celiac disease) Having history of major cardiovascular events Involved in other clinical trials in the past 1 months before randomization Allergic to garlic Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Arterial Stiffness;Blood pressure;Inflammatory markers;Lipid profile;Fatigue severity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Body mass index (BMI);Body composition;Blood glucose profile;Grip strength;Knee extensor strength; | — |
Countries
Malaysia
Contacts
Public ContactAssociate Professor Dr. Hasnah Haron
Centre for Healthy Ageing & Wellness (H-Care),Faculty of Health Sciences, UKM
Outcome results
None listed